Sygnature Discovery Limited
Tomas Baikstis is an experienced Associate Principal Scientist and Lead Scientist at Sygnature Discovery, with a focus on anti-inflammatory, diabetes, immuno-oncology, and neurodegeneration programs involving GPCRs, enzymes, and protein-protein interactions. Prior to this role, Tomas worked as a Research Chemist at Redag Crop Protection Ltd and completed a PhD in Organic Chemistry at the University of Liverpool under the guidance of Prof. P. Andrew Evans and Dr. Christophe Aïssa. Tomas's educational background includes a Master of Science in Drug and Natural Product Chemistry from Leibniz Universität Hannover and a Bachelor of Science in Chemistry from Latvijas Universitate.
This person is not in any teams
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.